Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24524N0893
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc., a Rockville, Maryland-based pharmaceutical manufacturer, received a $12,559.90 firm fixed-price delivery order from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 on September 6, 2024, for JYNARQUE 90MG-30MG. The contract, which has no set-aside designation, is scheduled for completion on September 11, 2024, with performance occurring in Pittsburgh, Pennsylvania. This delivery order represents a routine procurement of Jynarque (tolvaptan), a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in the veteran population.
This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and draws from Otsuka's established Blanket Purchase Agreement with the VA National Acquisition Center valued at $83.3 million through March 26, 2026. The company's large federal supply schedule contract for pharmaceuticals demonstrates its established capability to serve the VA's healthcare mission. The delivery order supports the VA's provision of specialized pharmaceutical treatments to veterans across multiple Integrated Service Networks, enabling efficient procurement of critical medications through the existing indefinite delivery vehicle framework.
Quick answers
Who was awarded contract 36C24524N0893?
36C24524N0893 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 6, 2024.
How much is contract 36C24524N0893 worth?
The government has obligated $12,560 on 36C24524N0893.
Is contract 36C24524N0893 an order under another contract?
Yes. 36C24524N0893 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0893 competed?
The extent of competition for 36C24524N0893 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award